Switch to:
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Median P/S Value
$78.11 (As of Today)

This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use P/S Ratio instead of P/E Ratio or P/B Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median P/S Value is calculated as trailing twelve months (TTM) revenue per share times 10-Year median P/S ratio. Valeant Pharmaceuticals International Inc's revenue per share for the trailing twelve months (TTM) ended in Mar. 2014 was $19.9. Valeant Pharmaceuticals International Inc's 10-Year median P/S ratio is 3.93. Therefore, the Median P/S Value for today is $78.11.

As of today, Valeant Pharmaceuticals International Inc's share price is $123.47. Valeant Pharmaceuticals International Inc's median P/S value is $78.11. Therefore, Valeant Pharmaceuticals International Inc's Price to Median P/S Value Ratio for today is 1.60.

VRX' s 10-Year Price to Median P/S Value Range
Min: 0.5   Max: 6.57
Current: 1.6

0.5
6.57

During the past 13 years, the highest Price to Median P/S Value Ratio of Valeant Pharmaceuticals International Inc was 6.57. The lowest was 0.50. And the median was 1.57.

VRX's Price to Median P/S Value is ranked higher than
63% of the 806 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 1.23 vs. VRX: 1.60 )

Definition

Valeant Pharmaceuticals International Inc's Median P/S Value for today is calculated as

Median P/S Value=Total Annual Sales / Shares Outstanding*10-Year Median P/S Ratio
=Revenue per Share (TTM)*10-Year Median P/S Ratio
=19.9*3.93
=78.21

10-Year Median P/S Ratio is 3.93.
Valeant Pharmaceuticals International Inc's revenue per share for the trailing twelve months (TTM) ended in Mar. 2014 was 3.48 (Jun. 2013 ) + 4.62 (Sep. 2013 ) + 6.17 (Dec. 2013 ) + 5.63 (Mar. 2014 ) = $19.9.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use P/S Ratio instead of P/E Ratio or P/B Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company’s value.

Valeant Pharmaceuticals International Inc's Price to Median P/S Value Ratio for today is calculated as

Price to Median P/S Value=Share Price/Median P/S Value
=123.47/78.21
=1.58

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

P/E Ratio, P/B Ratio, P/S Ratio, Intrinsic Value (DCF Projected), Intrinsic Value (DCF), Intrinsic Value (DE), Graham Number, GAVA


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
medpsvalue 21.4323.0826.0220.5718.6020.3322.9629.7144.4769.71

Valeant Pharmaceuticals International Inc Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
medpsvalue 29.7133.9537.2941.1344.4747.2650.3657.3469.7178.11
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide